Tissue Regenix enters UK distribution agreement for porcine tendon product

Writer,

Regenerative medical devices company Tissue Regenix said it had entered into a distribution agreement and secured its first order with a speciality supplier of orthopaedic and biologic products.

The agreement entailed the UK distribution of the company's OrthoPure XT decellularized porcine tendon product, following its recent CE Mark approval in June.

Britain's National Health Service and the private healthcare sector would have access to OrthoPure XT under the terms of the distribution agreement.

Tissue Regenix said it would initially focus on commercialisation of OrthoPure XT in the UK before commencing a gradual roll-out into certain other European countries over time.

It had received the first 'modest' order and delivery was expected to take place during the fourth quarter of 2020.

Demand for the product line was expected to increase in 2021 as additional distribution opportunities were identified, the company said.


Related content

Tissue Regenix expects annual revenue to slip 2%

Regenerative medical devices company Tissue Regenix said it expected its annual revenue to slip 2%, in what it described as a 'strong' performance against a...

Mon, 08/02/2021 - 08:05


Tissue Regenix appoints CFO

Medical devices company Tissue Regenix has appointed David Cocke as CFO and director to the board with immediate effect.

Mr Cocke has over 29...

Thu, 21/01/2021 - 08:24


Tissue Regenix makes first porcine tendon deliveries

Regenerative medical devices company Tissue Regenix said it had notched first deliveries of its porcine tendon product, with additional shipments expected in early 2021.

The...

Wed, 02/12/2020 - 07:39


Tissue Regenix appoints Daniel Lee as CEO

Regenerative medical devices company Tissue Regenix said it had appointed Daniel Lee as chief executive.

Lee was currently the head of the company's US operations,...

Tue, 17/11/2020 - 08:50


Tissue Regenix losses narrow on cost cutting

Regenerative medical devices company Tissue Regenix posted a narrower first-half loss after it cut overheads.

Pre-tax losses for the six months through June amounted to...

Wed, 02/09/2020 - 07:47